Bearishness Around Pfizer Gilead Sparks Opportunity
Wall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
Knowing when to use cash back versus rewards points can enhance your savings. Our guide provides insights for better decision-making.
26,047 articlesWall Street traders weigh a contrarian opportunity as Pfizer and Gilead trade below fair value amid rising bearish se...
IREN stock fell sharply as investors reprice AI infrastructure bets after a month of steep declines. While the sector...
Sandisk surged more than 3,000% in the past year, turning heads and raising questions about valuation and future move...
Bitcoin’s spot market remains in a cautious lull even as futures and options activity picks up. Analysts say the shif...
Kraft Heinz trimmed guidance after a challenging quarter, McCormick posted steady growth with margin pressure, and Ho...
Broadcom is edging toward a 52-week peak as AI demand fuels revenue growth and capital returns. Analysts weigh buy, h...
SpaceX signals a potential $75 billion IPO, elevating CFO Bret Johnsen to the center of a new phase focused on govern...
Nvidia trades at a clear premium as AI demand drives semiconductors higher, while Adobe sits at a comparatively modes...
Goldfinch outlines a phased wind-down of its Prime unit, shifting from growth to borrower recoveries and testing whet...
As retail faces slower discretionary spend, Walmart doubles down on automation, ads, and marketplace scale, while Cos...
IBM’s dramatic one-day plunge coincided with blockbuster bank profits, fueling a debate over whether markets are misp...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...